Healthcare Triangle, Inc. (HCTI)

NASDAQ: HCTI · Real-Time Price · USD

Compare

8.53

+1.30 (17.98%)

At close: Feb 13, 2026, 4:00 PM EST

8.03

-0.50 (-5.86%)

After-hours: Feb 13, 2026, 7:58 PM EST

Healthcare Triangle Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Healthcare Triangle in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Healthcare Triangle.

Recommendation Trends

Rating	Jul '22	Aug '22
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Constantine Davides EF Hutton	EF Hutton	Strong Buy Maintains $597,600 → $298,800	Strong Buy	Maintains	$597,600 → $298,800	+3,502,830.83%	Sep 28, 2022
Constantine Davides EF Hutton	EF Hutton	Strong Buy Initiates $597,600	Strong Buy	Initiates	$597,600	+7,005,761.66%	Mar 14, 2022

Financial Forecast

Revenue This Year

17.19M

from 11.70M

47.01%

from 11.70M

Revenue Next Year

24.91M

from 17.19M

44.88%

from 17.19M

EPS This Year

-1.87

from -

EPS Next Year

-0.54

from -1.87

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	31.34M	35.27M	45.89M	33.20M	11.70M	17.19M	24.91M
Revenue Growth	9.06%	12.54%	30.10%	-27.64%	-64.77%	47.01%	44.88%
EPS	-	-	-	-	-	-1.87	-0.54
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	17.7M	25.6M
Avg	17.2M	24.9M
Low	16.5M	23.9M

Revenue Growth

Revenue Growth	2025	2026
High	51.3%	49.1%
Avg	47.0%	44.9%
Low	41.2%	39.2%

EPS Forecast

EPS	2025	2026
High	-1.92	-0.56
Avg	-1.87	-0.54
Low	-1.79	-0.52

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.